Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Shows potential in modulating signaling pathways involved in tumor growth and cell proliferation. Also employed in the development of PET radiotracers for imaging neurological disorders due to its ability to cross the blood-brain barrier and bind selectively to specific enzyme targets. Its trifluoromethyl and fluorophenyl groups enhance metabolic stability and binding affinity, making it valuable in optimizing drug candidates for improved efficacy and pharmacokinetics.